Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Rigel Announces Poster Presentations at FOCIS Annual Meeting | ||
By: PR Newswire Association LLC. - 20 Jun 2018 | Back to overview list |
|
SOUTH SAN FRANCISCO, Calif., June 20, 2018 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dr. Anne-Marie Duliege, Chief Medical Officer, will be presenting two posters on fostamatinib at the Federation of Clinical Immunology Societies (FOCIS) Annual Meeting in San Francisco, June 20-23, 2018. Poster presentation details: Poster presentation details: About Rigel (www.rigel.com) Please see www.TAVALISSE.com for full Prescribing Information. Contact: Raul Rodriguez Media Contact: Jessica Daitch
View original content with multimedia:http://www.prnewswire.com/news-releases/rigel-announces-poster-presentations-at-focis-annual-meeting-300669691.html SOURCE Rigel Pharmaceuticals, Inc. |
||
|
||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |